Literature DB >> 17434394

Hydroxychloroquine in systemic lupus erythematosus.

Nathalie Costedoat-Chalumeau1, Zahir Amoura2, Jean-Sébastien Hulot2, Philippe Lechat2, Jean-Charles Piette2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17434394     DOI： 10.1016/S0140-6736(07)60591-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

2.  A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires.

Authors:  Nathalie Costedoat-Chalumeau; Frédéric Houssiau; Peter Izmirly; Véronique Le Guern; Sandra Navarra; Meenakshi Jolly; Guillermo Ruiz-Irastorza; Gabriel Baron; Eric Hachulla; Nancy Agmon-Levin; Yehuda Shoenfeld; Francesca Dall'Ara; Jill Buyon; Christophe Deligny; Ricard Cervera; Estibaliz Lazaro; Holy Bezanahary; Gaëlle Leroux; Nathalie Morel; Jean-François Viallard; Christian Pineau; Lionel Galicier; Ronald Van Vollenhoven; Angela Tincani; Hanh Nguyen; Guillaume Gondran; Noel Zahr; Jacques Pouchot; Jean-Charles Piette; Michelle Petri; David Isenberg
Journal:  Clin Pharmacol Ther       Date:  2017-11-09       Impact factor: 6.875

3.  The combination of hydroxychloroquine and 2-deoxyglucose enhances apoptosis in breast cancer cells by blocking protective autophagy and sustaining endoplasmic reticulum stress.

Authors:  Ning Zhou; Qingyun Liu; Xiao Wang; Lixin He; Tao Zhang; Han Zhou; Xinying Zhu; Tianhong Zhou; Ganzhen Deng; Changwei Qiu
Journal:  Cell Death Discov       Date:  2022-06-11

4.  Glucocorticoid receptor genetic polymorphisms is associated with improvement of health-related quality of life in Chinese population with systemic lupus erythematosus.

Authors:  Yan-Feng Zou; Jian-Hua Xu; Fa-Ming Pan; Jin-Hui Tao; Sheng-Qian Xu; Hui Xiao; Shuang Liu; Jing Cai; Li Lian; Pei-Ling Chen; De-Guang Wang; Sheng-Xiu Liu; Chun-Mei Liang; Qian-Ling Ye; Guo Tian; Min Wu; Yuan-Yuan Gu; Hai-Feng Pan; Hong Su; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2015-08-09       Impact factor: 2.980

5.  Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.

Authors:  Tiphaine Lenfant; Sawsen Salah; Gaëlle Leroux; Elodie Bousquet; Véronique Le Guern; François Chasset; Camille Francès; Nathalie Morel; Julie Chezel; Thomas Papo; Patrice Cacoub; Luc Mouthon; Gaëlle Guettrot-Imbert; Pascal Cohen; Alexis Régent; Martine Mauget-Faÿsse; Jean-Charles Piette; Moez Jallouli; Nathalie Costedoat-Chalumeau
Journal:  Rheumatology (Oxford)       Date:  2020-12-01       Impact factor: 7.580

6.  Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus.

Authors:  Karim Sacre; Lindsey A Criswell; Joseph M McCune
Journal:  Arthritis Res Ther       Date:  2012-06-27       Impact factor: 5.156

7.  Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.

Authors:  Michael Sticherling
Journal:  Biologics       Date:  2011-02-14

8.  Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up.

Authors:  Yoland Schoindre; Moez Jallouli; Marie-Laure Tanguy; Pascale Ghillani; Lionel Galicier; Olivier Aumaître; Camille Francès; Véronique Le Guern; Frédéric Lioté; Amar Smail; Nicolas Limal; Laurent Perard; Hélène Desmurs-Clavel; Du Le Thi Huong; Bouchra Asli; Jean-Emmanuel Kahn; Laurent Sailler; Félix Ackermann; Thomas Papo; Karim Sacré; Olivier Fain; Jérôme Stirnemann; Patrice Cacoub; Gaëlle Leroux; Judith Cohen-Bittan; Jean-Sébastien Hulot; Philippe Lechat; Lucile Musset; Jean-Charles Piette; Zahir Amoura; Jean-Claude Souberbielle; Nathalie Costedoat-Chalumeau
Journal:  Lupus Sci Med       Date:  2014-06-07

9.  Hydroxychloroquine inhibits CD154 expression in CD4+ T lymphocytes of systemic lupus erythematosus through NFAT, but not STAT5, signaling.

Authors:  Shu-Fen Wu; Chia-Bin Chang; Jui-Mei Hsu; Ming-Chi Lu; Ning-Sheng Lai; Chin Li; Chien-Hsueh Tung
Journal:  Arthritis Res Ther       Date:  2017-08-09       Impact factor: 5.156

10.  Investigating interactions between chloroquine/hydroxychloroquine and their single enantiomers and angiotensin-converting enzyme 2 by a cell membrane chromatography method.

Authors:  Qianqian Jia; Jia Fu; Peida Liang; Saisai Wang; Yamin Wang; Xin Zhang; Huaxin Zhou; Liyang Zhang; Yanni Lv; Shengli Han
Journal:  J Sep Sci       Date:  2021-11-17       Impact factor: 3.614
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.